FIELD: medicine. SUBSTANCE: medicinal agent has, wt.-%: fusidic acid 1.7-2.3; gentamycin sulfate 0.085-0.115; preserving agent nipagin 0.068-0.084; purified water 8.5-10.5, and 1,2-propylene glycol - the rest up to 100. Agent used as drops shows enhanced effectiveness against staphylococci and can be used in otorhinolaryngology. EFFECT: enhanced effectiveness of agent, no toxicity.
| Title | Year | Author | Number |
|---|---|---|---|
| OINTMENT | 1993 |
|
RU2076697C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SPRAY FOR WOUND SURFACE TREATMENT | 2010 |
|
RU2416394C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| AGENT FOR TREATMENT OF DERMATOLOGICAL DISEASES | 2001 |
|
RU2197247C2 |
| TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
| TOPICAL USE OF DIOXIDIN FOR TREATMENT OF OTOLARYNGOLOGICAL DISEASES | 2022 |
|
RU2809120C1 |
| METHOD FOR COMBATTING OTITIS MEDIA AND OTITIS EXTERNA | 2019 |
|
RU2749857C1 |
| ANTIBACTERIAL DRUG IN FORM OF OINTMENT FOR TREATING EYE DISEASES IN ANIMALS | 2015 |
|
RU2580631C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
